EXHIBIT
10.62


 


INVESTOR
RIGHTS AGREEMENT


 


THIS
INVESTOR RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of April, 2020 by and among
Investview, Inc. a Nevada corporation (the “Company”), and DBR Capital, LLC, a Pennsylvania limited
liability company (the “Investor”).


 


RECITALS


 


WHEREAS,
the Company and the Investor are parties to that certain Securities Purchase Agreement of even date herewith (the “Purchase
Agreement”); and


 


WHEREAS,
in order to induce the Company to enter into the Purchase Agreement and to induce the Investor to invest funds in the Company
pursuant to the Purchase Agreement, the Investor and the Company hereby agree that this Agreement shall govern the rights of the
Investor to cause the Company to register shares of Common Stock issuable to the Investor, to receive certain information from
the Company, and to participate in future equity offerings by the Company, and shall govern certain other matters as set forth
in this Agreement;


 


NOW,
THEREFORE, the parties hereby agree as follows:


 


1. Definitions.
For purposes of this Agreement:


 


1.1 “Affiliate”
means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under
common control with such Person, including without limitation any general partner, managing member, officer, director or trustee
of such Person, or any venture capital fund or registered investment company now or hereafter existing that is controlled by one
or more general partners, managing members or investment adviser of, or shares the same management company or investment adviser
with, such Person.


 


1.2 “Board
of Directors” means the board of directors of the Company.


 


1.3 “Certificate
of Incorporation” means the Company’s Certificate of Incorporation, as amended and/or restated from time to time.


 


1.4 “Common
Stock” means shares of the Company’s common stock, par value $0.001 per share.


 


1.5 “Convertible
Notes” means those certain Convertible Secured Promissory Notes issued by the Company to the Investor pursuant to the
Purchase Agreement.


 


1.6
“Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become
subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim or liability
(or any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material
fact contained in any registration statement of the Company, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required
to be stated therein, or necessary to make the statements therein not misleading; or (iii) any violation or alleged violation
by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange
Act, any state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any state
securities law.


 


1.7
“Derivative Securities” means any securities or rights convertible into, or exercisable or exchangeable for
(in each case, directly or indirectly), Common Stock, including options, warrants and the convertible notes issued
pursuant to the Purchase Agreement.


 


1.8 “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.


 


1.9
“Excluded Registration” means
(i) a registration relating to the sale or grant of securities to employees of the Company or a subsidiary pursuant to a stock
option, stock purchase, equity incentive or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a
registration on any form that does not include substantially the same information as would be required to be included in a registration
statement covering the sale of the Registrable Securities; or (iv) a registration in which the only Common Stock being registered
is Common Stock issuable upon conversion of debt securities that are also being registered.


 




    	1 



    	 



    

 


1.10
“Form S-1” means such form under the Securities Act as in effect on the date hereof or any successor registration
form under the Securities Act subsequently adopted by the SEC.


 


1.11 “Form
S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities
Act subsequently adopted by the SEC that permits forward incorporation of substantial information by reference to other documents
filed by the Company with the SEC.


 


1.12 “GAAP”
means generally accepted accounting principles in the United States as in effect from time to time.


 


1.13
“IPO” means the Company’s
first underwritten public offering of its Common Stock under the Securities Act.


 


1.14 “Investor
Director” means each of the directors of the Company designated by the Investor pursuant to Sections 1.2(a) and 1.2(b)
of the Voting Agreement.


 


1.15
“Key Employee” means any executive-level employee (including, division director and vice president-level
positions) as well as any employee who, either alone or in concert with others, develops, invents, programs, or designs any Company
Intellectual Property (as defined in the Purchase Agreement).


 


1.16 “New
Securities” means, collectively, equity securities of the Company, whether or not currently authorized, as well as rights,
options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible
or exchangeable into or exercisable for such equity securities.


 


1.17
“Person” means any individual,
corporation, partnership, trust, limited liability company, association or other entity.


 


1.18
“Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the Convertible
Note; (ii) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon
conversion and/or exercise of any other securities of the Company, acquired by the Investor
after the date hereof; and (iii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right,
or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of,
the shares referenced in clauses (i) and (ii) above.


 


1.19
“Registrable Securities then outstanding” means the number of shares determined by adding the number
of shares of outstanding Common Stock that are Registrable Securities and the number of shares of
Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible
securities that are Registrable Securities.


 


1.20 “SEC”
means the Securities and Exchange Commission.


 


1.21 “SEC
Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.


 


1.22 “SEC
Rule 145” means Rule 145 promulgated by the SEC under the Securities Act.


 


1.23 “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


1.24
“Selling Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable
to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements
of the Investor Counsel borne and paid by the Company as provided in Subsection 2.3.


 




    	2 



    	 



    

 


1.25 “Voting
Agreement” means that certain Voting Agreement, dated as of the date hereof, by and among the Company, the Investor
and the other parties thereto.


 


2. Registration
Rights. The Company covenants and agrees as follows:


 


2.1 Mandatory
Registration.


 


(a) The
Company shall prepare, and, as soon as practicable, but in no event later than thirty (30) days from the date hereof, file with
the SEC a registration statement on Form S-1 (or Form S-3 if available) covering the resale with respect to all Registrable Securities
of Investor issued or issuable upon conversion of the Convertible Notes and use its commercially reasonable efforts to cause such
registration statement to become effective and keep such registration statement effective for a period of up to one hundred twenty
(120) days following the tenth (10th) anniversary of the date hereof or, if earlier, until the distribution contemplated
in the registration statement has been completed; provided, however, that period shall be extended for a period
of time equal to the period the Investor refrains, at the request of an underwriter of Common Stock (or other securities) of the
Company, from selling any securities included in such registration. If such registration statement (or any successor registration
statement) shall expire, the Company shall, prior to such expiration, file a replacement registration statement that is in compliance
with this Subsection 2.1(a). If at any time and from time to time the Investor is issued any additional Registrable Securities,
the Company shall prepare and file a registration statementwith respect to such additional Registrable Securities in compliance
with this Subsection 2.1(a).


 


(b) In
furtherance of Subsection 2.1(a), the Company shall, as expeditiously as reasonably possible:


 


(i) prepare
and file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection with
such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities
covered by such registration statement;


 


(ii) furnish
to the Investor such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities Act,
and such other documents as the Investor may reasonably request in order to facilitate their disposition of its Registrable Securities;


 


(iii) register
and qualify the securities covered by such registration statement under such other securities or blue-sky laws of such jurisdictions
as shall be reasonably requested by the Investor; provided that the Company shall not be required to qualify to do business
or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject
to service in such jurisdiction and except as may be required by the Securities Act;


 


(iv) in
the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the underwriter(s) of such offering;


 


(v) use
its commercially reasonable efforts to cause all such Registrable Securities covered by such registration statement to be listed
on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar
securities issued by the Company are then listed;


 


(vi) provide
a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number
for all such Registrable Securities, in each case not later than the effective date of such registration;


 


(vii)
promptly make available for inspection by the
Investor, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any
attorney or accountant or other agent retained by any such underwriter or selected by the Investor, all financial and other records,
pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and
independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant,
or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement
and to conduct appropriate due diligence in connection therewith;


 




    	3 



    	 



    

 


 


(viii) notify
the Investor, promptly after the Company receives notice thereof, of the time when such registration statement has been declared
effective or a supplement to any prospectus forming a part of such registration statement has been filed; and


 


(ix) after
such registration statement becomes effective, notify the Investor of any request by the SEC that the Company amend or supplement
such registration statement or prospectus.


 


In
addition, the Company shall ensure that, at all times after any registration statement covering a public offering of securities
of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s
directors may implement a trading program under Rule 10b5-1 of the Exchange Act.


 


2.2 Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section
2 with respect to the Registrable Securities that the Investor shall furnish to the Company such information regarding itself,
the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to
effect the registration of the Registrable Securities.


 


2.3
Expenses of Registration. All expenses (other
than Selling Expenses) incurred in connection with registrations, filings, or qualifications pursuant to Section 2, including
all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the
Company, and the reasonable fees and disbursements of counsel for the Investor (“Investor Counsel”),
shall be borne and paid by the Company.


 


2.4 Indemnification.
If any Registrable Securities are included in a registration statement under this Section 2:


 


(a)
To the extent permitted by law, the Company will
indemnify and hold harmless the Investor, and the partners, members, officers, directors, and stockholders of the Investor; legal
counsel and accountants for the Investor; any underwriter (as defined in the Securities Act) for the Investor; and each Person,
if any, who controls the Investor or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages,
and the Company will pay to the Investor, underwriter, controlling Person, or other aforementioned Person any legal, including
reasonable attorney’s fees, or other expenses reasonably incurred thereby in connection with investigating or defending
any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however,
that the indemnity agreement contained in this Subsection 2.4 (a) shall not apply to amounts paid in settlement of any
such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall
not be unreasonably withheld, conditioned or delayed, nor shall the Company be liable for any Damages to the extent that they
arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished
by or on behalf of the Investor, underwriter, controlling Person, or other aforementioned Person expressly for use in connection
with such registration.


 


(b)
To the extent permitted by law, the Investor,
severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has
signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal
counsel and accountants for the Company, any underwriter (as defined in the Securities Act), the Investor, and any controlling
Person of any such underwriter or the Investor, against any Damages, in each case only to the extent that such Damages arise out
of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on
behalf of the Investor expressly for use in connection with such registration; and the Investor will pay to the Company and each
other aforementioned Person any legal, including reasonable attorney’s fees, or other expenses reasonably incurred thereby
in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses
are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.4 (b) shall
not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the
consent of the Investor, which consent shall not be unreasonably withheld, conditioned or delayed; and provided further
that in no event shall the aggregate amounts payable by the Investor by way of indemnity or contribution under Subsections
2.4 (b) and 2.4(d) exceed the proceeds from the offering received by the Investor (net of any Selling
Expenses paid by the Investor), except in the case of fraud or willful misconduct by the Investor.


 




    	4 



    	 



    

 


(c) Promptly
after receipt, but no later than ten (10) business days after reciept by an indemnified party under this Subsection 2.4
of notice of the commencement of any action (including any governmental action) for which a party may be entitled to indemnification
hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Subsection 2.4, give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right
to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying
party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party (together with all other indemnified parties that may be represented without conflict
by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying
party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due
to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such
action. The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action as
set forth herein this Subsection 2.4, shall relieve such indemnifying party of any liability to the indemnified party under
this Subsection 2.4, to the extent that such failure materially prejudices the indemnifying party’s ability to defend
such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any
indemnified party otherwise than under this Subsection 2.4.


 


(d)
To provide for just and equitable contribution
to joint liability under the Securities Act in any case in which either: (i) any party otherwise entitled to indemnification hereunder
makes a claim for indemnification pursuant to this Subsection 2.4 but it is judicially determined (by the entry of a final
judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of
appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.4 provides
for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto
for which indemnification is provided under this Subsection 2.4, then, and in each such case, such parties will contribute
to the aggregate losses, claims, damages, liabilities, legal expenses, including attorney’s fees, or other expenses to which
they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each
of the indemnifying party and the indemnified party in connection with the statements, omissions, or other actions
that resulted in such loss, claim, damage, liability, legal expenses, including attorney’s fees, or other expenses, as well
as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified
party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material
fact, or the omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party
and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement
or omission; provided, however, that, in any such case (x) the Investor will not be required to contribute any amount
in excess of the public offering price of all such Registrable Securities offered and sold by the Investor pursuant to such registration
statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; and provided further
that in no event shall the Investor’s liability pursuant to this Subsection 2.4 (d), when combined with the amounts
paid or payable by the Investor pursuant to Subsection 2.4 (b), exceed the proceeds from the offering received by
the Investor (net of any Selling Expenses paid by the Investor), except in the case of willful misconduct
or fraud by the Investor.


 


(e) Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.


 


(f) Unless
otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations
of the Company and the Investor under this Subsection 2.4 shall survive the completion of any offering of Registrable Securities
in a registration under this Section 2, and otherwise shall survive the termination of this Agreement.


 


2.5 Reports
Under Exchange Act. With a view to making available to the Investor the benefits of SEC Rule 144 and any other rule or regulation
of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration or pursuant
to a registration on Form S-3, the Company shall:


 


(a)
make and keep available adequate current
public information, as those terms are understood and defined in SEC Rule 144, at all times;


 


(b) use
commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company
under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements);
and


 


(c)
furnish to the Investor, so long as the Investor
owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a written statement by
the Company that it has complied with the reporting requirements of SEC Rule 144, the Securities Act, and the Exchange Act, or
that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after the Company so qualifies);
and (ii) such other information as may be reasonably requested in availing the Investor of any rule or regulation of the SEC that
permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting
requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form).


 




    	5 



    	 



    

 


3. Information
Rights.


 


3.1 Delivery
of Company Information. The Company shall deliver to the Investor each of the following; provided that the Investor may
at any time and from time to time direct the Company to, for the period specified by the Investor, discontinue delivering all
or any portion of the following:


 


(a)
as soon as practicable, but in any event within
ninety (90) days after the end of each fiscal year of the Company (i) a balance sheet as of the end of such year, (ii) statements
of income and of cash flows for such year, and a comparison between (x) the actual amounts as of and for such fiscal year and
(y) the comparable amounts for the prior year and as included in the Budget (as defined in Subsection 3.1(d)) for such
year, with an explanation of any material differences between such amounts and a schedule as to the sources and applications of
funds for such year, and (iii) a statement of stockholders’ equity as of the end of such year, all such financial
statements audited and certified by Haynie & Company (or such other independent public accountant approved by the
Board of Directors, including each of the Investor Directors);


 


(b)
as soon as practicable, but in any event within
forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements
of income and cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of stockholders’ equity
as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i)
be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required in accordance with
GAAP);


 


(c)
as soon as practicable, but in any event within
fifteen (15) days of the end of each month, an unaudited income statement for such month, and an unaudited balance
sheet as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be
subject to normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP);


 


(d)
as soon as practicable, but in any event thirty
(30) days before the end of each fiscal year, a budget and business plan for the next fiscal year (collectively, the “Budget”),
approved by the Board of Directors (including each of the Investor Directors) and prepared on a monthly basis, including
balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets
or revised budgets prepared by the Company;


 


(e) with
respect to the financial statements called for in Subsection 3.1(a), Subsection 3.1(b) and Subsection 3.1(c),
an instrument executed by the chief financial officer and chief executive officer of the Company certifying that such financial
statements were prepared in accordance with GAAP consistently applied with prior practice for earlier periods (except as otherwise
set forth in Subsection 3.1(b) and Subsection 3.1(c)) and fairly present the financial condition of the Company
and its results of operation for the periods specified therein;


 


(f) promptly
following the occurrence thereof, notice of any material events or occurrences with respect to the Company or any of its subsidiaries,
including material claims, proceedings, suits or actions (whether threatened or materialized), loss of or termination of material
contracts or customers, material events that with the passage of time will materially impact future operations of the Company
(or its subsidiary companies) or any facility or property where Company conducts its operations, loss of key employees, material
or adverse changes with respect to regulatory or reporting matters and material defaults under any credit facilities, and any
other event or occurrence that would reasonably be expected to cause a material adverse effect with respect to the Company or
any of its subsidiaries; and


 


(g) such
other information relating to the financial condition, business, prospects, or corporate affairs of the Company as the Investor
may from time to time reasonably request.


 


If,
for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such
period all financial statements (including, for the avoidance of doubt, annual, quarterly and monthly financial statements) delivered
pursuant to the foregoing sections shall include both the consolidated financial statements and consolidating financial statements
of the Company and all such consolidated subsidiaries.


 


3.2 Inspection.
The Company shall permit the Investor, at the Investor’s expense, to visit and inspect the Company’s properties; examine
its books of account and records; and discuss the Company’s affairs, finances, and accounts with its officers, during normal
business hours of the Company as may be reasonably requested by the Investor.


 




    	6 



    	 



    

 


3.3
Confidentiality. The Investor agrees that the
Investor will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in
the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice
of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes
known to the public in general (other than as a result of a breach of this Subsection 3.3 by the Investor), (b) is or has
been independently developed or conceived by the Investor without use of the Company’s confidential information, or (c)
is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality
such third party may have to the Company; provided, however, that the Investor may disclose confidential information
(i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection
with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from the Investor,
if such prospective purchaser agrees to be bound by the provisions of this Subsection 3.3; (iii) to any existing
or prospective Affiliate, partner, member, stockholder, or wholly owned subsidiary of the Investor in the ordinary course
of business, provided that the Investor informs such Person that such information is confidential and directs
such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, regulation,
rule, court order or subpoena, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable
steps to minimize the extent of any such required disclosure.


 


4. Rights
to Future Stock Issuances.


 


4.1 Right
of First Offer. Subject to the terms and conditions of this Subsection 4.1 and applicable securities laws, if the Company
proposes to offer or sell any New Securities, the Company shall first offer such New Securities to the Investor. The Investor
shall be entitled to apportion the right of first offer hereby granted to it in such proportions as it deems appropriate, among
(i) itself, (ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person
having “beneficial ownership,” as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of the Investor
(“Investor Beneficial Owners”).


 


(a) The
Company shall give notice (the “Offer Notice”) to the Investor, stating (i) its bona fide intention to offer
such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it
proposes to offer such New Securities.


 


(b)
By notification to the Company within thirty
(30) days after the Offer Notice is given, the Investor may elect to purchase or otherwise acquire, at the price and on the terms
specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Common Stock then
held by the Investor (including all shares of Common Stock then issuable (directly or indirectly) upon conversion
and/or exercise, as applicable, of any Derivative Securities then held by the Investor) bears to the total Common
Stock of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Derivative
Securities then outstanding). The closing of any sale pursuant to this Subsection 4.1(b) shall occur within the later of
thirty (30) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Subsection
4.1 (c).


 


(c) If
all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Subsection 4.1(b),
the Company may, during the thirty (30) day period following the expiration of the periods provided in Subsection 4.1(b),
offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and
upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement
for the sale of the New Securities within such period, or if such agreement is not consummated within thirty (30) days of the
execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless
first reoffered to the Investor in accordance with this Subsection 4.1.


 


5. Additional
Covenants.


 


5.1 Insurance.
To the extent not already in place, the Company shall obtain, within ninety (90) days of the date hereof, from financially sound
and reputable insurers (i) Directors and Officers liability insurance, (ii) term “key-person” insurance on Joseph
Cammarata and (iii) general commercial liability property insurance with respect to the Company and its subsidiaries, each in
an amount and on terms and conditions satisfactory to the Board of Directors, including each of the Investor Directors, and will
thereafter maintain such insurance policies until such time as the Board of Directors, including at least one Investor Director,
determines that such insurance should be discontinued. The key-person policy shall name the Company as loss payee, and neither
policy shall be cancelable by the Company without prior approval by the Board of Directors, including each of the Investor Directors.
Notwithstanding any other provision of this Section 5.1 to the contrary, for so long as an Investor Director is serving
on the Board of Directors, the Company shall not cease to maintain a Directors and Officers liability insurance policy in an amount
of at least $2 million during the remainder of 2020 and $3 million during 2021 and thereafter unless approved by each Investor
Director, and the Company, shall annually, within ninety (90) days after the end of each fiscal year of the Company, deliver to
the Investor a certification that such a Directors and Officers liability insurance policy remains in effect. For clarification,
Company at no time after the insurance is in place as required by this Section 5.1, allow such insurance to lapse without the
approval of the Board of Directors, including at least one Investor Director.


 




    	7 



    	 



    

 


5.2 Employee
Agreements. Within sixty (60) days of the date hereof, the Company will cause (i) each Person now or hereafter employed
by it or by any subsidiary (or engaged by the Company or any subsidiary as a consultant/independent contractor) with access to
confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement; and (ii)
each Key Employee to enter into a one (1) year noncompetition and nonsolicitation agreement, substantially in the form approved
by the Board of Directors, including each of the Investor Directors. In addition, the Company shall not amend, modify, terminate,
waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement between
the Company and any employee, without the consent of the Investor Directors.


 


5.3 Matters
Requiring Investor Director Approval. So long as the Investor is entitled to designate an Investor Director, the Company hereby
covenants and agrees with the Investor that it shall not, without approval of the Board of Directors, which approval must include
the affirmative vote of at least one Investor Director:


 


(a) liquidate,
dissolve or wind-up the business and affairs of the Company, effect any merger or consolidation, any sale, lease, transfer, exclusive
license or other disposition, in a single transaction or series of related transactions, of all or substantially all the assets
of the Company, or any other similar transaction, or consent to any of the foregoing;


 


(b) amend,
alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Company;


 


(c) create,
or authorize the creation of, or issue or obligate itself to issue shares of, any additional class or series of capital stock,
or increase the authorized number of shares of any additional class or series of capital stock of the Company;


 


(d) purchase
or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any shares
of capital stock of the Company other than repurchases of stock from former employees, officers, directors, consultants or other
persons who performed services for the Company or any subsidiary in connection with the cessation of such employment or service
at the lower of the original purchase price or the then-current fair market value thereof;


 


(e) create,
or authorize the creation of, or issue, or authorize the issuance of any debt security or create any lien or security interest
(except for purchase money liens or statutory liens of landlords, mechanics, materialmen, workmen, warehousemen and other similar
persons arising or incurred in the ordinary course of business) or incur other indebtedness for borrowed money, including but
not limited to obligations and contingent obligations under guarantees, or permit any subsidiary to take any such action with
respect to any debt security lien, security interest or other indebtedness for borrowed money, other than equipment leases or
trade payables incurred in the ordinary course of business;


 


(f) create,
or hold capital stock in, any subsidiary that is not wholly owned (either directly or through one or more other subsidiaries)
by the Company, or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue, any shares
of any class or series of capital stock, or sell, transfer or otherwise dispose of any capital stock of any direct or indirect
subsidiary of the Company, or permit any direct or indirect subsidiary to sell, lease, transfer, exclusively license or otherwise
dispose (in a single transaction or series of related transactions) of all or substantially all of the assets of such subsidiary;


 


(g) increase
or decrease the authorized number of directors constituting the Board of Directors;


 


(h) make
any loan or advance to, or own any stock or other securities of, any subsidiary or other corporation, partnership, or other entity
other than subsidiaries existing on the date hereof;


 




    	8 



    	 



    

 


(i) make
any loan or advance to any Person, including, without limitation, any employee or director of the Company or any subsidiary, except
advances and similar expenditures in the ordinary course of business or under the terms of an employee stock or option plan approved
by the Board of Directors which includes the affirmative vote of at least one Investor Director;


 


(j) guarantee,
directly or indirectly, any indebtedness except for trade accounts of the Company or any subsidiary arising in the ordinary course
of business;


 


(k) otherwise
enter into or be a party to any transaction with any director, officer, or employee of the Company or any “associate”
(as defined in Rule 12b-2 promulgated under the Exchange Act) of any such Person, including without limitation any “management
bonus” or similar plan providing payments to employees in connection with a change of control, except for transactions contemplated
by this Agreement and transactions made in the ordinary course of business and pursuant to reasonable requirements of the Company’s
business and upon fair and reasonable terms that are approved by the Investor Directors;


 


(l) enter
into any agreement or engage in any transaction with a value (whether payable to or by the Company) in excess of $25,000;


 


(m) hire,
terminate, or change the compensation of the executive officers, member of the Board of Directors or Key Employees, including
approving any option grants or stock awards to executive officers, members of the Board of Directors or Key Employees;


 


(n) change
the principal business of the Company, enter new lines of business, or exit the current line of business;


 


(o) sell,
assign, license, pledge, or encumber any assets of the Company, including including but not limited to technology, software, patents
or intellectual property, other than sales of inventory in the ordinary course of business and licenses granted in the ordinary
course of business;


 


(p) enter
into any corporate strategic relationship involving the payment, contribution, or assignment by the Company or to the Company
of money or assets greater than $25,000;


 


(q) alter
the Company’s tax status or make any material determination with respect to the Company’s tax obligations;


 


(r) effect
transfers, including transfers of cash or assets, or enter into any agreement or engage in any other transaction between the Company
and any Company subsidiary or between Company subsidiaries;


 


(s) make
any change or determination with respect to any material or adverse compliance matters, or take any action that materially or
adversely affects the Company’s compliance regime;


 


(t) make
any change or determination with respect to any material or adverse regulatory or reporting matters of the Company, or take any
action that materially or adversely affects the Company’s regulatory or reporting regime, or settle any material litigation
or dispute;


 


(u) permit
any subsidiary to do any of the foregoing.


 


5.4 Board
Matters. Unless otherwise determined by the vote of a majority of the directors then in office (which shall include the Investor
Directors), the Board of Directors shall meet at least monthly unless approved by each Investor Director, in accordance with an
agreed-upon schedule. The Company shall reimburse the non-employee directors for all reasonable out-of-pocket travel expenses
incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors.
The Company shall cause to be established, as soon as practicable after such request, and will maintain, an (i) audit and (ii)
compensation committee, each of which shall consist solely of non-management directors. Each non-employee director shall be entitled
in such person’s discretion to be a member of any committee of the Board of Directors.


 




    	9 



    	 



    

 


5.5 Successor
Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other Person and is
not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision
shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification
of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained
in the Company’s Bylaws, the Certificate of Incorporation, or elsewhere, as the case may be.


 


5.6
Indemnification Matters. The Company hereby acknowledges
that one (1) or more of the directors nominated to serve on the Board of Directors by the Investors (each an “Investor
Director”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by one or more
of the Investors and certain of their Affiliates (collectively, the “Investor Indemnitors”). The Company hereby
agrees (a) that it is the indemnitor of first resort (i.e., its obligations to any such Investor Director are primary and
any obligation of the Investor Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by such Investor Director are secondary), (b) that it shall be required to advance the full amount of expenses incurred
by such Investor Director and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid
in settlement by or on behalf of any such Investor Director to the extent legally permitted and as required by the Company’s
Certificate of Incorporation or Bylaws of the Company (or any agreement between the Company and such Investor Director), without
regard to any rights such Investor Director may have against the Investor Indemnitors, and, (c) that it irrevocably waives, relinquishes
and releases the Investor Indemnitors from any and all claims against the Investor Indemnitors for contribution, subrogation or
any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Investor Indemnitors
on behalf of any such Investor Director with respect to any claim for which such Investor Director has sought indemnification
from the Company shall affect the foregoing and the Investor Indemnitors shall have a right of contribution and/or be subrogated
to the extent of such advancement or payment to all of the rights of recovery of such Investor Director against the Company. The
Investor Directors and the Investor Indemnitors are intended third-party beneficiaries of this Subsection 5.6 and shall
have the right, power and authority to enforce the provisions of this Subsection 5.6 as though they were a party to this
Agreement.


 


5.7 Right
to Conduct Activities. The Company hereby agrees
and acknowledges that DBR Capital, LLC (together with its Affiliates) is a professional investment organization, and as such reviews
the business plans and related proprietary information of many enterprises, some of which may compete directly or indirectly with
the Company’s business (as currently conducted or as currently propose to be conducted). The Company hereby agrees that,
to the extent permitted under applicable law, DBR Capital, LLC (and its Affiliates) shall not be liable to the Company for any
claim arising out of, or based upon, (i) the investment by DBR Capital, LLC (or its Affiliates) in any entity competitive with
the Company, or (ii) actions taken by any partner, officer, employee or other representative of DBR Capital, LLC (or its Affiliates)
to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive
company, an investor or otherwise, and whether or not such action has a detrimental effect on the Company; provided, however,
that the foregoing shall not relieve (x) the Investor from liability associated with the unauthorized disclosure of the Company’s
confidential information obtained pursuant to this Agreement, or (y) any director or officer of the Company from any liability
associated with his or her fiduciary duties to the Company.


 


6. Miscellaneous.


 


6.1 Successors
and Assigns. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable
by the respective parties hereto, the successors and permitted assigns of the Investor and the successors of the Company, whether
so expressed or not. None of the parties hereto may assign its rights or obligations hereof without the prior written consent
of the other party, except that the Investor may, without the prior consent of the Company, assign its rights to any of its Affiliates
that purchases Registrable Securities or to which the Investor transfers Registrable Securities. This Agreement shall not inure
to the benefit of or be enforceable by any other third party Person.


 


6.2 Counterparts;
Effectiveness. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts,
with the same effect as if all parties had signed the same document. All such counterparts (including counterparts delivered by
facsimile, email or other electronic format) shall be deemed an original, shall be construed together and shall constitute one
and the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts hereof
signed by all of the other parties hereto.


 


6.3 Headings.
The headings of the Sections and paragraphs of this Agreement have been inserted for convenience of reference only and do not
constitute a part of this Agreement and are not to be considered in construing or interpreting this Agreement.


 




    	10 



    	 



    

 


6.4 Notices.


 


(a) All
notices, demands, requests, consents, approvals, and other communications required or permitted to be given pursuant to this Agreement
shall be in writing and shall be delivered (a) in hand by person with written receipt of the person to whom such notice is intended;
(b) by registered or certified mail, postage prepaid, return receipt requested; or (c) by a generally recognized commercial courier
service or overnight delivery service, (Federal Express or UPS), for next business day delivery, postage prepaid, with delivery
receipt requested. All notices sent in accordance with this Subsection 6.4 shall be deemed “Delivered” unless
otherwise specified herein, the same day if delivered by hand in person with receipt and signature of the intended recipient or
by an authorized officer of the intended recipient; if by registered or certified mail, three (3) business days after the same
is deposited in the U.S. Mail; or if sent by a commercial courier service or overnight delivery service for next business day
delivery, one (1) business day after payment and receipt of mailing. All communications shall be sent to the respective parties
at their address as set forth on the signature pages hereto, or to such email address, facsimile number or address as subsequently
modified by written notice given in accordance with this Subsection 6.4.


 


(b) Consent
to Electronic Notice. Notwithstanding any contrary language set forth in subsection (a) immediately above, the Investor consents
to the delivery of any stockholder notice by electronic transmission pursuant to the Nevada Revised Statutes, Title 7, Chapter
78, Section 370 (or any successor thereto) at the electronic mail address or the facsimile number set forth below such Investor’s
name on the Schedules hereto, as updated from time to time by notice to the Company, or as on the books of the Company. The Investor
agrees to promptly notify the Company of any change in such stockholder’s electronic mail address, and that failure to do
so shall not affect the foregoing.


 


6.5 Amendments
and Waivers. Any term of this Agreement may be amended, modified or terminated and the observance of any term of this Agreement
may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written
consent of the Company and the Investor. No waivers of or exceptions to any term, condition, or provision of this Agreement, in
any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, condition, or
provision.


 


6.6 Severability.
If any provision of this Agreement shall be found by any court of competent jurisdiction to be invalid or unenforceable, the parties
hereby waive such provision to the extent that it is found to be invalid or unenforceable. Such provision shall, to the maximum
extent allowable by law, be modified by such court so that it becomes enforceable, and, as modified, shall be enforced as any
other provision hereof, all the other provisions hereof continuing in full force and effect. However, if any such invalid or unenforceable
provision cannot by modified to become enforceable, then such provision(s) shall be stricken from the Agreement in its/their entirety
and all the other provisions hereof shall be continuing in full force and effect.


 


6.7 Aggregation
of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose of
determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate.


 


6.8 Entire
Agreement. This Agreement, the Purchase Agreement and that certain Investor Rights Agreement, dated as of the date hereof, by
and between the Company and the Investor constitute the full and entire understanding and agreement between the parties with respect
to the subject matter hereof, and this agreement supersedes and replaces all other prior agreements, written or oral, among the
parties hereto with respect to the subject matter hereof.


 


6.9 Governing
Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without
regard to its conflict of law principles. Any suit, action or proceeding seeking to enforce any provision of, or based on any
matter arising out of or in connection with, this Agreement or the transactions contemplated hereby may be brought in any federal
or state court located in the Borough of Manhattan, the City of New York and State of New York, and each of the parties hereby
consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding
and irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying
of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought
in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any
party anywhere in the world, whether within or without the jurisdiction of any such court.


 




    	11 



    	 



    

 


Waiver
of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS
TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS,
THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND
ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING, WITHOUT LIMITATION,
CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS
SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH
PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT
SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.


 


6.10 Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement, upon any
breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching
or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar
breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach
or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to
any party, shall be cumulative and not alternative.


 


6.11 Remedies;
Cumulative. The parties acknowledge that a breach by either party of its obligations hereunder will cause irreparable harm to
the other party, by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the parties acknowledges
that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach
or threatened breach by a party of the provisions of this Agreement, that the non-defaulting party shall be entitled, in addition
to all other available remedies at law or in equity, and in addition to the penalties assessable herein or allowed by law, to
an injunction or injunctions restraining, preventing or curing any breach of this Agreement and to enforce specifically the terms
and provisions thereof, without the necessity of showing economic loss and without any bond or other security being required.
None of the rights, powers or remedies conferred upon the parties pursuant to the terms and provisions of this Agreement shall
be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to every other right, power or
remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise.


 


6.12 Costs
of Enforcement. If any party to this Agreement seeks to enforce its rights under this Agreement by legal proceedings, the non-prevailing
party shall pay all costs and expenses incurred by the prevailing party, including, without limitation, all reasonable attorneys’
fees.


 


6.13 Further
Assurances. At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at
the request of any other party, and without any additional consideration, the parties agree to provide further information or
assurances; execute and deliver such additional agreements, documents and instruments; and take such other actions and do such
other things, as may be necessary or appropriate to carry out the terms and provisions of this Agreement, the intent of the parties
and give effect to the transactions contemplated hereby.


 


[Remainder
of Page Intentionally Left Blank. Authorized Signatures on Following Page]


 




    	12 



    	 



    

  






IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.


 


	 	INVESTVIEW, INC.
	 	 	 
	 	By:	 
	 	Name:	Joseph Cammarata
	 	Title:	Chief Executive Officer


 


	 	Address:	Investview, Inc.
	 	 	234 Industrial Way West
	 	 	Building A. Suite 202
	 	 	Eatontown, NJ 07724
	 	Email:	joe@investview.com


 


	 	With a copy to:
	 	 	 
	 	 	Michael Best & Friedrish LLP
	 	 	790 N. Water Street
	 	 	Suite2500
	 	 	Milwaukee, WI 53202
	 	 	Attention: Kevin C. Timken


 


IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.


 


	 	INVESTOR:
	 	 
	 	DBR CAPITAL, LLC
	 	 	 
	 	By:
	 
	 	Name:	David B. Rothrock
	 	Title:	Managing Member Executive


 


		Address:	1645 Kecks Road
	 	 	Breinigsville,
PA 18031
	 	Email:	dbr@rothrock.com


 


	 	with copies to:
	 	 	 
	 	 	Morgan, Lewis & Bockius LLP
	 	 	1701 Market Street
	 	 	Philadelphia, Pennsylvania 19103-2921
	 	 	Attn: Michael J. Pedrick, Esq.


 




    	13